---
figid: PMC4393718__jcmm0016-2894-f2
figtitle: EphA/ephrinA bidirectional signalling
organisms:
- NA
pmcid: PMC4393718
filename: jcmm0016-2894-f2.jpg
figlink: /pmc/articles/PMC4393718/figure/fig02/
number: F2
caption: EphA/ephrinA bidirectional signalling. (A) Stimulation of ephrinA5 recruits
  and activates the Src-family kinase, FYN. Subsequently, FYN induces a change in
  the cellular architecture and adhesion of ephrinA5-expressing cells  and results
  in mitogen-activated protein kinase (MAPK) activation . (B) EphA4 activates signal
  transducers and STAT3 . EphA receptors directly activate GTPases of the Rho family
  (RHOA, RAC1 and CDC42) through the exchange factor Ephexin ,. This pathway involves
  EphA2 and PI3 kinase in endothelial cells . EphA2 inhibits Akt , and inactivates
  focal adhesion kinase (FAK) through the SHP2 phosphatase . EphA2 activates RHOA
  through FAK ,. EphA1 inhibits integrin-linked kinase (ILK). EphB/ephrinB bidirectional
  signalling. (C) Growth Factor Receptor Bound protein 4 (GRB4) contains a SH2 domain
  and can link ephrinB ligands to a signalling network that modifies cell morphology
  . EphrinB1 disrupts focal adhesions through GRB4 . The phosphatase PTP-BL is recruited
  to the ephrinB carboxy-terminal tail. PTP-BL dephosphorylates ephrinB and inactivates
  Src . PDZ-RGS3 binds constitutively to ephrinB and catalyses the hydrolysis of GTP
  to GDP in the G-Alpha subunit of heterotrimeric GPCR. It also inhibits SDF1–mediated
  cell chemotaxis through the CXCR4 . (D) EphB forward signalling activates RAC1 and
  CDC42 exchange factors ,,. EphB2 activates Ras GAP to inhibit the H-RAS and R-RAS
  ,. EphB2 regulates cell positioning via PI3K . The EphB4 receptor suppresses breast
  cancer cell tumorigenicity through an Abl-Crk pathway . EphB2 regulates cell proliferation
  through an Abl-cyclin D1 pathway .
papertitle: Eph receptors and ephrins as targets for cancer therapy.
reftext: Hong-Qing Xi, et al. J Cell Mol Med. 2012 Dec;16(12):2894-2909.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5472063
figid_alias: PMC4393718__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC4393718__F2
ndex: 24d4b0df-df39-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4393718__jcmm0016-2894-f2.html
  '@type': Dataset
  description: EphA/ephrinA bidirectional signalling. (A) Stimulation of ephrinA5
    recruits and activates the Src-family kinase, FYN. Subsequently, FYN induces a
    change in the cellular architecture and adhesion of ephrinA5-expressing cells  and
    results in mitogen-activated protein kinase (MAPK) activation . (B) EphA4 activates
    signal transducers and STAT3 . EphA receptors directly activate GTPases of the
    Rho family (RHOA, RAC1 and CDC42) through the exchange factor Ephexin ,. This
    pathway involves EphA2 and PI3 kinase in endothelial cells . EphA2 inhibits Akt
    , and inactivates focal adhesion kinase (FAK) through the SHP2 phosphatase . EphA2
    activates RHOA through FAK ,. EphA1 inhibits integrin-linked kinase (ILK). EphB/ephrinB
    bidirectional signalling. (C) Growth Factor Receptor Bound protein 4 (GRB4) contains
    a SH2 domain and can link ephrinB ligands to a signalling network that modifies
    cell morphology . EphrinB1 disrupts focal adhesions through GRB4 . The phosphatase
    PTP-BL is recruited to the ephrinB carboxy-terminal tail. PTP-BL dephosphorylates
    ephrinB and inactivates Src . PDZ-RGS3 binds constitutively to ephrinB and catalyses
    the hydrolysis of GTP to GDP in the G-Alpha subunit of heterotrimeric GPCR. It
    also inhibits SDF1–mediated cell chemotaxis through the CXCR4 . (D) EphB forward
    signalling activates RAC1 and CDC42 exchange factors ,,. EphB2 activates Ras GAP
    to inhibit the H-RAS and R-RAS ,. EphB2 regulates cell positioning via PI3K .
    The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk
    pathway . EphB2 regulates cell proliferation through an Abl-cyclin D1 pathway
    .
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MKP-4
  - p38b
  - rl
  - Axn
  - CAP
  - SMC3
  - Cpn
  - Capa
  - capt
  - bel
  - SERCA
  - Cadps
  - Pak
  - mbt
  - Src42A
  - Csk
  - Src64B
  - Fak
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - vap
  - ras
  - Ras64B
  - Ras85D
  - scb
  - Abl
  - Abi
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Crk
  - .na.character
  - Cdc42
  - Ilk
  - Akt
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Rac1
  - Rac2
  - Mtl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Rok
  - act
  - Act5C
  - Act42A
  - Actbeta
  - 'On'
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTG1
  - AXIN1
  - AXIN2
  - CTAA1
  - LNPEP
  - SERPINB6
  - HACD1
  - CAP1
  - SORBS1
  - BRD4
  - CAP2
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - SGCA
  - SRC
  - FGR
  - FYN
  - YES1
  - PTK2
  - RASA1
  - RGS6
  - KRAS
  - HRAS
  - NRAS
  - NCK2
  - EPHB1
  - EPHB2
  - EPHB3
  - EPHB4
  - EPHB6
  - EPHA1
  - EPHA2
  - EPHA3
  - EPHA4
  - EPHA5
  - EPHA6
  - EPHA7
  - EPHA8
  - EPHA10
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - JAK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NGEF
  - CRK
  - CDC42
  - ILK
  - AKT1
  - AKT2
  - AKT3
  - STAT3
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - RRAS
  - TBL1XR1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - ROCK1
  - ROCK2
  - SERPINA3
  - ACTG1
  - ACTG2
  - FHL5
  - ACOT7
  - ACTBL2
  - POTEKP
  - POTEM
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - Cancer
---
